ANIMATION

HuLuc 63

Share this animation:

PDL BioPharma asked XVIVO to show how a novel humanized antibody, HuLuc 63, appears to induce anti-tumor effects by binding to a protein expressed only on the surface of myeloma cells. This initiates antibody-dependent cytotoxic activity which targets myeloma cells while leaving healthy cells intact.

Share It:
Contact XVIVO

Client


PDL BioPharma

I came to XVIVO with only a few basic thoughts, and from these ideas, they worked out an excellent and striking image that perfectly conveyed the scientific point. I was very pleased with the experience, and I would recommend XVIVO to anyone that wants to explain complicated scientific ideas with clear and professional images.

Jeff Moffitt, Graduate Student, Bustamante Lab, Department of Physics, University of California-Berkeley
Share this animation: